when should i stop taking glp 1 GLP-1 Medications Infographic What Happens When You Stop

While glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are known to increase heart rate (HR), it is insufficiently recognized that the extent varies greatly between the various agonists and is affected by the assessment methods employed

However, some types of eating disorders could worsen with GLP1-RA and require monitoring and treatment by registered dietitian and/or behavioral health providers who specialize in eating disorders, with appropriate referrals to higher levels of care for disordered eating.

Our take: GLP-1 microdosing is booming on social media trend and although weight loss drugmakers Novo and Lilly have neither studied nor endorsed mini doses, its another tactic for telehealth providers like Noom to stay in the weight loss game

A Breakthrough Award, New Evidence in Parkinson's and Heart Disease

For further details, please refer to the [User Guide]